Document is current

Any future updates will be listed below

Evaluation of Progression-Free Survival and Overall Survival of Epidermal Growth Factor Receptor-Positive Metastatic Lung Adenocarcinoma Patients Treated with Erlotinib

Crossref DOI link: https://doi.org/10.47176/mjiri.36.31

Published Online: 2022-02-15

Update policy: https://doi.org/10.47176/mjiri/crossmark_policy

About CrossMark